DS

Donald E. Staunton

IC Icos: 5 patents #36 of 106Top 35%
DI Dana-Farber Cancer Institute: 4 patents #223 of 1,343Top 20%
TR The Center For Blood Research: 4 patents #4 of 33Top 15%
Overall (All Time): #325,670 of 4,157,543Top 8%
15
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
7981415 Humanized PAI-1 antibodies Maximiliano Vasquez 2011-07-19
7771720 Humanized PAI-1 antibodies Maximiliano Vasquez 2010-08-10
6797270 Functional derivatives of the intercellular adhesion molecule ICAM-1 in anti-viral therapy Timothy A. Springer 2004-09-28
6777191 Use of functional derivatives of the intercellular adhesion molecule ICAM-1 in diagnosis of viral infection Timothy A. Springer 2004-08-17
6511664 Intercellular adhesion molecule—2 and its binding ligands Timothy A. Springer, Michael L. Dustin 2003-01-28
6436403 Pharmaceutical composition of the intercellular adhesion molecule ICAM-1 for use in anti-viral prophylactic therapy Timothy A. Springer 2002-08-20
6210914 Method to identify proteins which bind to integrin regulatory proteins Brian P. Lispky 2001-04-03
5958705 Cytoplasmic modulators of integrin regulation/signaling Brian P. Lispky 1999-09-28
5948891 Cytoplasmic modulators of integrin binding Edith A. Salot Harris 1999-09-07
5922570 Cytoplasmic Modulators of Integrin Binding/Signalling Edith Salot Harris 1999-07-13
5693483 Cytoplasmic modulators of integrin binding/signalling Edith Salot Harris 1997-12-02
5565550 Antibodies to ICAM-2, and fragments thereof Timothy A. Springer, Michael L. Dustin 1996-10-15
5512660 Purified ICAM-2 and fragment thereof Timothy A. Springer, Michael L. Dustin 1996-04-30
5489533 Isolated nucleic acid molecules encoding ICAM-2 Timothy A. Springer, Michael L. Dustin 1996-02-06
5288854 Functional derivatives of ICAM-1 which are substantially capable of binding to LFA-1 but are substantially incapable of binding to MAC-1 Michael Diamond, Timothy A. Springer 1994-02-22